Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell ...
The team used human stem cells to create embryo-like structures dubbed “hematoids” that mirror some features of early human ...
Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find ...
In a breakthrough cancer therapy development, scientists at MIT and Harvard Medical School created a new way of designing ...
Nutrition experts share the best time to take vitamin B, plus who should be supplementing, how much you need, and what all ...
Bayer AG has struck a deal with Atara Biotherapeutics to jointly work on Atara's CAR-T cell anti-tumour treatments, as the German group firms up its commitment to build a specialist cell and gene ...
Aera Therapeutics Presents Preclinical Data and Announces Nomination of First Development Candidate, AERA-109, a Targeted In Vivo CAR-T Therapy for B Cell-mediated Autoimmune Diseases Preclinical data ...
Developing cardiac inflammatory organoid models incorporating multiple cell lineages is vital for novel therapies.
MIT and Harvard scientists have designed an advanced type of immune cell called a CAR-NK cell that can destroy cancer while ...
Living with an autoimmune disease often means navigating a lifelong, complex condition. A recent study estimates that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback